Orgasmic suppression treatment (ADT), upon which the androgen receptor pathway is focused, is the primary treatment dealing with men who have progressed to advanced stages of prostate cancer (Kirby et al., 2011; Huggins and Hodges, 1941). Here, AR is linked to prostate carcinoma.